Skip to main navigation
Skip to search
Skip to main content
Universitat Autònoma de Barcelona Research Portal Home
Help & FAQ
Link opens in a new tab
Català
Español
English
Search content at Universitat Autònoma de Barcelona Research Portal
Home
Profiles
Research units
Projects
Research output
Datasets
Theses and Supervised work
Homogeneous assay for anti-HIV antibody detection based on new B-Galactosidase molecular probes
Villaverde Corrales, Antonio Pedro
(Principal Investigator)
Aris Giralt, Anna
(Scholar)
Curbasí Morera, Rafael
(Investigator)
DIVISION OF BIOCHEMICAL ENGINEERING
(Investigator)
Ferrer Miralles, Neus
(Investigator)
Department of Genetics and Microbiology
Institute of Biotechnology and Biomedicine "Vicent Villar Palasi" (IBB)
Universitat Politècnica de Catalunya (UPC)
German Research Centre for Biotechnology (Gesellschaft für Biotechnologische Forschung)
Overview
Fingerprint
Research output
(1)
Project Details
Description
Not available
Status
Finished
Effective start/end date
1/12/98
→
30/11/00
Collaborative partners
German Research Centre for Biotechnology (Gesellschaft für Biotechnologische Forschung)
(Coordinator)
(lead)
Funding
Directorate-General for Science, Research and Development (DG XII), European Commission:
€628,058.00
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
β-Galactosidase (β-Gal)
Keyphrases
100%
HIV Antibodies
Keyphrases
100%
Homogeneous Assay
Keyphrases
100%
Molecular Probe
Keyphrases
100%
Antibody Detection
Keyphrases
100%
Galactosidase
Pharmacology, Toxicology and Pharmaceutical Science
100%
Human Immunodeficiency Virus Antibody
Pharmacology, Toxicology and Pharmaceutical Science
100%
Anti-Human Immunodeficiency Virus
Pharmacology, Toxicology and Pharmaceutical Science
100%
Research output
Research output per year
2016
2016
2016
1
Article
Research output per year
Research output per year
Nanostructured recombinant cytokines: A highly stable alternative to short-lived prophylactics
Torrealba, D., Parra, D.,
Seras-Franzoso, J.
, Vallejos-Vidal, E.,
Yero, D.
,
Gibert, I.
,
Villaverde, A.
,
Garcia-Fruitós, E.
&
Roher, N.
,
1 Nov 2016
,
In:
Biomaterials.
107
,
p. 102-114
13 p.
Research output
:
Contribution to journal
›
Article
›
Research
›
peer-review
Nanostructures
100%
Highly Stable
100%
Recombinant Cytokines
100%
Cytokine
100%
Recombinant Cytokine
100%
48
Link opens in a new tab
Citations (Scopus)